Company profile FATE
After 39 days of this quarter the interest is at 23.0. Based on that we can calculate that during remaining 52 days it will total up to 54.0. fate therapeutics -stock expected interest is significantly lower compared to previous quarter (-61.7%) and same quarter last year (-84.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 60 | 145 141.7% QoQ | 150 3.4% QoQ | 150 0.0% QoQ |
| 2020 | 153 155.0% YoY 2.0% QoQ | 107 -26.2% YoY -30.1% QoQ | 129 -14.0% YoY 20.6% QoQ | 172 14.7% YoY 33.3% QoQ |
| 2021 | 197 28.8% YoY 14.5% QoQ | 204 90.7% YoY 3.6% QoQ | 111 -14.0% YoY -45.6% QoQ | 170 -1.2% YoY 53.2% QoQ |
| 2022 | 219 11.2% YoY 28.8% QoQ | 205 0.5% YoY -6.4% QoQ | 160 44.1% YoY -22.0% QoQ | 168 -1.2% YoY 5.0% QoQ |
| 2023 | 344 57.1% YoY 104.8% QoQ | 139 -32.2% YoY -59.6% QoQ | 97 -39.4% YoY -30.2% QoQ | 141 -16.1% YoY 45.4% QoQ |
| 2024 | 23 -93.3% YoY -83.7% QoQ | - | - | - |
The average 5 years interest of fate therapeutics -stock was 12.43 per week. The last year interest of fate therapeutics -stock compared to the last 5 years has changed by -22.53%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -6.05%.